Drug-Induced Urticaria: Causes and Clinical Courses

September 2011 | Volume 10 | Issue 9 | Original Article | 1019 | Copyright © September 2011


Ni-on Rutnin MD,a Kanokvalai Kulthanan MD,a Papapit Tuchinda MD,a Kowit Jongjarearnprasert MSb

aDepartment of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
bDepartment of Pharmacy, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

  1. Stubb S, Heikkila H, Kauppinen K. Cutaneous reactions to drugs: A series of in-patients during a five-year period. Acta Derm Venereol. 1994;74(4):289-291.
  2. Nettis E, Marcandrea M, Maggio GD, et al. Retrospective analysis of drug-induced urticaria and angioedema: A survey of 2287 patients. Immunopharmacol Immunotoxicol. 2001;23(4):585-595.
  3. Kaplan AP. Urticaria and Angioedema. In: Wolff K, Goldsmith LA, Katz SI, eds. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York, NY: McGraw-Hill; 2008: 330-342.
  4. Grattan CE, Black AK. Urticaria and Angioedema. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Spain: Mosby; 2008: 261-276.
  5. Causality assessment of suspected adverse reactions [Internet database]. Available at: http://www.who-umc.org/DynPage. aspx?id=22682. Accessed December 1, 2010.
  6. Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol. 2008;74(4):430.
  7. Puavilai S, Choonhakarn C. Drug eruptions in Bangkok: A 1-year study at Ramathibodi Hospital. Int J Dermatol. 1998;37(10):747-751.
  8. Shipley D, Ormerod AD. Drug-induced urticaria. Recognition and treatment. Am J Clin Dermatol. 2001;2(3):151-158.
  9. Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol. 2000;84(1):101-106.
  10. Lobera T, Navarro B, Del Pozo MD, et al. Nine cases of omeprazole allergy: Cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol. 2009;19(1):57-60.
  11. Garrido Fernandez S, Cumplido JA, Rabano A, et al. Allergy to proton pump inhibitors: Diagnosis and assessment of cross-reactivity. J Investig Allergol Clin Immunol. 2008;18(2):140-141.
  12. Gonzalez P, Soriano V, Lopez P, Niveiro E. Anaphylaxis to proton pump inhibitors. Allergol Immunopathol (Madr). 2002;30(6):342-343.
  13. Perez Pimiento AJ, Prieto Lastra L, Rodriguez Cabreros MI, et al. Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors. J Allergy Clin Immunol. 2006;117(3):707-708.
  14. Galindo PA, Borja J, Feo F, et al. Anaphylaxis to omeprazole. Ann Allergy Asthma Immunol. 1999;82(1):52-54.
  15. Woodall HE, Chiu A, Weissman DE. Opioid allergic reactions #175. J Palliat Med. 2008;11(10):1340-1341.
  16. Nasser SM, Ewan PW. Opiate-sensitivity: Clinical characteristics and the role of skin prick testing. Clin Exp Allergy. 2001;31(7):1014-1020.
  17. Ebo DG, Hagendorens MM, Bridts CH, et al. Allergic reactions occurring during anaesthesia: Diagnostic approach. Acta Clin Belg. 2004;59(1):34-43.
  18. Mertes PM, Laxenaire MC. Allergic reactions occuring during anasthesia. Eur J Anaesthesiol. 2002;19(4):240-262.
  19. Moneret-Vautrin DA, Kanny G. Anaphylaxis to muscle relaxants: Rational skin tests. Allerg Immunol (Paris). 2002;34(7):233-240.
  20. Hunskaar S, Donnell D. Clinical and pharmacological review of the efficacy of orphenadrine and its combination with paracetamol in painful conditions. J Int Med Res. 1991;19(2):71-87.
  21. Boussetta K, Ponvert C, Karila C, et al. Hypersensitivity reactions to paracetamol in children: A study of 25 cases. Allergy. 2005;60(9):1174-1177.
  22. Tsujino Y, Okamoto N, Morita E. Acetaminophen-induced urticaria without aspirin intolerance. J Dermatol. 2007;34(3):224-226.
  23. Sliesoraitis S, Chikhale PJ. Carboplatin hypersensitivity. Int J Gynecol Cancer. 2005;15(1):13-18.
  24. Koshiba H, Hosokawa K, Kubo A, et al. Incidence of Carboplatin- related hypersensitivity reactions in Japanese patients with gynecologic malignancies. Int J Gynecol Cancer. 2009;19(3):460-465.
  25. Morgan JS, Adams M, Mason MD. Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma. Eur J Cancer. 1994;30A(8):1205-1206.
  26. Markman M, Kennedy A, Webster K, et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol. 1999;17(4):1141.
  27. Polyzos A, Tsavaris N, Kosmas C, et al. Hypersensitivity reactions to carboplatin administration are common but not always severe: A 10-year experience. Oncology. 2001;61(2):129-133.
  28. Karsh J, Yang WH. An anaphylactic reaction to intra-articular triamcinolone: A case report and review of the literature. Ann Allergy Asthma Immunol. 2003;90(2):254-258.
  29. Murrieta-Aguttes M, Michelen V, Leynadier F, et al. Systemic allergic reactions to corticosteroids. J Asthma. 1991;28(5):329-339.

Address for Correspondence

Kanokvalai Kulthanan, MDDepartment of Dermatology, Faculty of MedicineSiriraj Hospital, Mahidol University2 Prannok Road, BangkoknoiBangkok 10700ThailandPhone: (662) 419-4333Fax: (662) 411-5031sikkt@mahidol.ac.th
Close Menu